Back to Search Start Over

Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China.

Authors :
Shujuan Zhao
Hongwei Zhao
Xianpei Wang
Chuanyu Gao
Yuhua Qin
Haixia Cai
Boya Chen
Jingjing Cao
Source :
Patient Preference & Adherence. Feb2017, Vol. 11, p213-220. 8p.
Publication Year :
2017

Abstract

Objectives: Warfarin is often used for ischemic stroke prevention in patients with atrial fibrillation (AF), but the factors affecting patient adherence to warfarin therapy have not been fully understood. Methods: A cross-sectional survey was conducted in AF patients undergoing warfarin therapy at least 6 months prior to the study. The clinical data collected using questionnaires by phone interviews included the following: 1) self-reported adherence measured by the Morisky Medication Adherence Scale-8©; 2) beliefs about medicines surveyed by Beliefs about Medicines Questionnaire (BMQ); and 3) drug knowledge as measured by the Warfarin Related Knowledge Test (WRKT). Demographic and clinical factors associated with warfarin adherence were identified using a logistic regression model. Results: Two hundred eighty-eight patients completed the survey and 93 (32.3%) of them were classified as nonadherent (Morisky Medication Adherence Scale-8 score,6). Major factors predicting warfarin adherence included age, cardiovascular disorders, WRKT, and BMQ; WRKT and BMQ were independently correlated with adherence to warfarin therapy by multivariate logistic regression analysis. Adherents were more likely to have greater knowledge scores and stronger beliefs in the necessity of their specific medications ([odds ratio {OR} =1.81, 95% confidence interval {CI} =1.51-2.15] and [OR =1.17, 95% CI =1.06-1.29], respectively). Patients with greater concerns about adverse reactions and more negative views of general harm were more likely to be nonadherent ([OR =0.76, 95% CI =0.69-0.84] and [OR =0.82, 95% CI =0.73-0.92], respectively). Conclusion: BMK and WRKT are related with patient behavior toward warfarin adherence. BMQ can be applied to identify patients at increased risk of nonadherence. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1177889X
Volume :
11
Database :
Academic Search Index
Journal :
Patient Preference & Adherence
Publication Type :
Academic Journal
Accession number :
121616956
Full Text :
https://doi.org/10.2147/PPA.S120962